{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:51Z","timestamp":1753890591675,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We aim to investigate the prognostic effects of metabolic syndrome (MS) on patients with non-ST elevated myocardial infarction (NSTEMI) after percutaneous coronary intervention (PCI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with NSTEMI undergoing PCI were consecutively collected. According to the presence or absence of MS, they were divided into two groups and followed up for 1 year. The endpoint was major adverse cardiovascular events (MACE), including all-cause death, unstable angina hospitalization, heart failure (HF) hospitalization, non-fatal recurrent myocardial infarction (MI), and target lesion revascularization. Also, six subgroups were made according to gender, age, left ventricular ejection fraction (LVEF), Global Registry of Acute Coronary Events (GRACE) score, hypersensitive troponin (hsTNT), and several diseased vessels. Cox proportional hazard model was adopted to analyze the effect of MS on MACE in all the patients and different subgroups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,295 patients were included in the current analysis and 660 (50.97%) of them had MS. About 88 patients were lost to follow-up, and the overall average follow-up was 315 days. MS was an independent risk factor for MACE (HR 1.714, CI 1.265\u20132.322, <jats:italic>p<\/jats:italic> = 0.001), all-cause death, heart failure (HF) hospitalization, and non-fatal recurrent MI. In the MS component, BMI \u226528 kg\/m<jats:sup>2<\/jats:sup> was positively associated with MACE. Subgroup analysis indicated the prognostic value of MS was more striking for patients with the following: age of &amp;gt;60, LVEF of \u226440%, GRACE of &amp;gt;140, multivessel disease, or hsTNT of &amp;gt;0.1 ng\/ml.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The MS was a robust adverse prognostic factor in patients diagnosed with NSTEMI, especially among those of older age and at higher ischemic risk. A BMI of \u226528 kg\/m<jats:sup>2<\/jats:sup> independently predicted the occurrence of MACE. Prognosis may be improved by controlling abdominal obesity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.912999","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T19:08:07Z","timestamp":1656011287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention"],"prefix":"10.3389","volume":"9","author":[{"given":"Li-Hong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1016\/j.numecd.2021.05.029","article-title":"Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome","volume":"31","author":"Zhou","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jjcc.2018.03.010","article-title":"Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment elevation myocardial infarction in men undergoing primary percutaneous coronary intervention","volume":"72","author":"Lee","year":"2018","journal-title":"J Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2677","DOI":"10.1097\/MD.0000000000002677","article-title":"Recent trends in hospitalization for acute myocardial infarction in beijing: increasing overall burden and a transition from ST-segment elevation to non-ST-segment elevation myocardial infarction in a population-based study","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine."},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3760\/cma.j.issn.0253-3758.2019.03.006","volume":"47","author":"Yong","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.hlc.2019.01.017","article-title":"Influence of BMI on short and long-term outcomes in patients with STEMI and LV dysfunction","volume":"29","author":"Samanta","year":"2020","journal-title":"Heart Lung Circ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1161\/CIRCULATIONAHA.105.559633","article-title":"Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the insulin resistance atherosclerosis study","volume":"112","author":"Hanley","year":"2005","journal-title":"Circulation."},{"key":"B9","first-page":"245","article-title":"Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases\u2013report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/01.CIR.0000073597.57414.A9","article-title":"ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College Of Cardiology\/American heart association task force on practice guidelines (ACC\/AHA\/ASE committee to update the 1997 guidelines for the clinical application of echocardiography)","volume":"108","author":"Cheitlin","year":"2003","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1210\/jc.2016-2477","article-title":"Metabolic syndrome among adults in China: the 2010 China noncommunicable disease surveillance","volume":"102","author":"Lu","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.jtcvs.2020.08.018","article-title":"Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: a 10-year follow-up of the veterans affairs database","volume":"163","author":"Deo","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jacc.2005.03.062","article-title":"Metabolic syndrome and risk of cardiovascular events after myocardial infarction","volume":"46","author":"Levantesi","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jns.2017.01.073","article-title":"Age, sex, and race\/ethnic temporal trends in metabolic syndrome prevalence among individuals with myocardial infarction or stroke in the United States","volume":"376","author":"Lekoubou","year":"2017","journal-title":"J Neurol Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/0003319710382419","article-title":"Prevalence, characteristics, and in-hospital outcomes of metabolic syndrome among acute coronary syndrome patients from Oman","volume":"62","author":"Al-Rasadi","year":"2011","journal-title":"Angiology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/2047487318763897","article-title":"Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome","volume":"25","author":"Cavallari","year":"2018","journal-title":"Eur J Prev Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.14740\/jocmr2655w","article-title":"Prevalence of metabolic syndrome and its clinical and angiographic profile in patients with naive acute coronary syndrome in north indian population","volume":"8","author":"Sinha","year":"2016","journal-title":"J Clin Med Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijcard.2015.07.010","article-title":"Comparison of resolute zotarolimus-eluting stents versus everolimus-eluting stents in patients with metabolic syndrome and acute myocardial infarction: propensity score-matched analysis","volume":"199","author":"Ji","year":"2015","journal-title":"Int J Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.hjc.2018.02.002","article-title":"Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation","volume":"59","author":"Lovic","year":"2018","journal-title":"Hellenic J Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/0003319711398473","article-title":"Impact of metabolic syndrome on clinical outcomes after drug-eluting stent implantation in patients with coronary artery disease","volume":"62","author":"Bin","year":"2011","journal-title":"Angiology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.numecd.2013.07.003","article-title":"Metabolic syndrome and long-term cardiovascular outcomes in NSTEMI with unstable angina","volume":"24","author":"Kul","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1093\/eurheartj\/ehv350","article-title":"The role of metabolic syndrome in heart failure","volume":"36","author":"Perrone-Filardi","year":"2015","journal-title":"Eur Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/archinte.165.10.1192","article-title":"Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction","volume":"165","author":"Zeller","year":"2005","journal-title":"Arch Intern Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1479164111430336","article-title":"Impact of metabolic syndrome on re-stenosis development: role of drug-eluting stents","volume":"9","author":"Goyal","year":"2012","journal-title":"Diab Vasc Dis Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1467-789X.2006.00248.x","article-title":"Elevated body mass index and mortality risk in the elderly","volume":"8","author":"Janssen","year":"2007","journal-title":"Obes Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.jacc.2010.11.058","article-title":"Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data","volume":"57","author":"Coutinho","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/07853890.2011.564202","article-title":"Visceral adiposity as a target for the management of the metabolic syndrome","volume":"44","author":"Kishida","year":"2012","journal-title":"Ann Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"36091","DOI":"10.1038\/srep36091","article-title":"Visceral adiposity and anthropometric indicators as screening tools of metabolic syndrome among low income rural adults in Xinjiang","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","article-title":"Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies","volume":"368","author":"Romero-Corral","year":"2006","journal-title":"Lancet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1311890","article-title":"Cardiovascular risk and events in 17 low-, middle-, and high-income countries","volume":"371","author":"Yusuf","year":"2014","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/eurpub\/ckt023","article-title":"Sizable variations in circulatory disease mortality by region and country of birth in six European countries","volume":"23","author":"Rafnsson","year":"2013","journal-title":"Eur J Public Health."},{"key":"B34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/heartjnl-2013-304474","article-title":"Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE\u2013Southall And Brent REvisited)","volume":"100","author":"Tillin","year":"2014","journal-title":"Heart."},{"key":"B35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2016.08.324","article-title":"Metabolic syndrome and its individual components with mortality among patients with coronary heart disease","volume":"224","author":"Chen","year":"2016","journal-title":"Int J Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/ajcn\/83.6.1248","article-title":"Does a diagnosis of metabolic syndrome have value in clinical practice?","volume":"83","author":"Grundy","year":"2006","journal-title":"Am J Clin Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.atherosclerosis.2011.12.016","article-title":"The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome","volume":"221","author":"Xu","year":"2012","journal-title":"Atherosclerosis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2014.06.029","article-title":"Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study","volume":"236","author":"Gianfagna","year":"2014","journal-title":"Atherosclerosis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3724\/SP.J.1263.2012.01172","article-title":"Metabolic syndrome vs. its components for prediction of cardiovascular mortality: a cohort study in Chinese elderly adults","volume":"9","author":"Sun","year":"2012","journal-title":"J Geriatr Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.numecd.2020.04.034","article-title":"Gender differences in the impact of metabolic syndrome components on mortality in older people: a systematic review and meta-analysis","volume":"30","author":"Sergi","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40292-013-0032-1","article-title":"Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI","volume":"21","author":"Cecchi","year":"2014","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1161\/CIRCULATIONAHA.107.182615","article-title":"Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American heart association council on clinical cardiology: in collaboration with the society of geriatric cardiology","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIR.0b013e318256f1e0","article-title":"2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"126","author":"Jneid","year":"2012","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.metabol.2012.11.002","article-title":"Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction","volume":"62","author":"Kim","year":"2013","journal-title":"Metabolism."},{"key":"B47","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1751-7176.2010.00371.x","article-title":"Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries","volume":"12","author":"Al Suwaidi","year":"2010","journal-title":"J Clin Hypertens."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jcmg.2012.01.008","article-title":"Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes","volume":"5","author":"Marso","year":"2012","journal-title":"JACC Cardiovasc Imag."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1253\/circj.cj-10-0219","article-title":"Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography","volume":"74","author":"Arai","year":"2010","journal-title":"Circ J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5681\/jcvtr.2012.003","article-title":"Evaluation of anthropometric indices of patients with left ventricle dysfunction fallowing first acute anterior myocardial infarction","volume":"4","author":"Azarfarin","year":"2012","journal-title":"J Cardiovasc Thorac Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.912999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T19:08:12Z","timestamp":1656011292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.912999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":50,"alternative-id":["10.3389\/fcvm.2022.912999"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.912999","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"912999"}}